MAGL targeted PROTAC degrader simultaneously enhances P53 for synergistic treatment of glioblastoma stem cell.
MAGL靶向PROTAC降解剂同时增强P53，以协同治疗胶质母细胞瘤干细胞
期刊:Cell Death Discovery
影响因子:7
doi:10.1038/s41420-025-02392-1
Yuan Zheng, Guo Meixia, Zhang Yue, Deng Yilin, Sun Biao, Hou Yaning, Wang Xin, Jin Xiong, Liu Yang, Shi Bingyang, Yin Jinlong
